Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manesh R Patel

Showing results (411-420 of 596) with videos related to

Pageof 60
Sort By:
European Heart Journal|April 14, 2017
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trialsIoanna Kosmidou, Björn Redfors, Harry P Selker, et al.
PLOS Digital Health|May 29, 2024
Frameworks for procurement, integration, monitoring, and evaluation of artificial intelligence tools in clinical settings: A systematic reviewSarim Dawar Khan, Zahra Hoodbhoy, Mohummad Hassan Raza Raja, et al.
Journal of the American Heart Association|May 31, 2021
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLIDMarc D Samsky, Anne Hellkamp, William R Hiatt, et al.
Vascular Medicine (London, England)|June 4, 2021
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y<sub>12</sub> inhibitors: Insights from the EUCLID trialJudith Hsia, Sarah T Kavanagh, Charles W Hopley, et al.
The American Journal of Cardiology|June 25, 2017
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)Jeffrey B Washam, Anne S Hellkamp, Yuliya Lokhnygina, et al.
The American Journal of Medicine|October 10, 2021
Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery DiseaseE Hope Weissler, Cassie B Ford, Dennis I Narcisse, et al.
American Heart Journal|December 26, 2021
The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trialMichael G Nanna, Sreekanth Vemulapalli, Christopher B Fordyce, et al.
Circulation. Cardiovascular Interventions|May 1, 2019
Identifying the Infarct-Related Artery in Patients With Non-ST-Segment-Elevation Myocardial InfarctionJohn F Heitner, Annamalai Senthilkumar, J Kevin Harrison, et al.
American Heart Journal|September 7, 2016
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trialRohan Shah, Anne Hellkamp, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|March 19, 2013
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trialJonathan P Piccini, Susanna R Stevens, Yuliya Lokhnygina, et al.
Pageof 60

Showing results (411-420 of 596) with videos related to

Sort By:
Pageof 60
European Heart Journal|April 14, 2017
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trialsIoanna Kosmidou, Björn Redfors, Harry P Selker, et al.
PLOS Digital Health|May 29, 2024
Frameworks for procurement, integration, monitoring, and evaluation of artificial intelligence tools in clinical settings: A systematic reviewSarim Dawar Khan, Zahra Hoodbhoy, Mohummad Hassan Raza Raja, et al.
Journal of the American Heart Association|May 31, 2021
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLIDMarc D Samsky, Anne Hellkamp, William R Hiatt, et al.
Vascular Medicine (London, England)|June 4, 2021
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y<sub>12</sub> inhibitors: Insights from the EUCLID trialJudith Hsia, Sarah T Kavanagh, Charles W Hopley, et al.
The American Journal of Cardiology|June 25, 2017
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)Jeffrey B Washam, Anne S Hellkamp, Yuliya Lokhnygina, et al.
The American Journal of Medicine|October 10, 2021
Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery DiseaseE Hope Weissler, Cassie B Ford, Dennis I Narcisse, et al.
American Heart Journal|December 26, 2021
The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trialMichael G Nanna, Sreekanth Vemulapalli, Christopher B Fordyce, et al.
Circulation. Cardiovascular Interventions|May 1, 2019
Identifying the Infarct-Related Artery in Patients With Non-ST-Segment-Elevation Myocardial InfarctionJohn F Heitner, Annamalai Senthilkumar, J Kevin Harrison, et al.
American Heart Journal|September 7, 2016
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trialRohan Shah, Anne Hellkamp, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|March 19, 2013
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trialJonathan P Piccini, Susanna R Stevens, Yuliya Lokhnygina, et al.
Pageof 60